Robert T. Foster serves as Executive at ContraVir Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert T. Foster has executed 6 insider transactions totaling $97.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 18, 2023 involved purchasing 1,600 shares valued at $9.0K.
Robert T. Foster currently holds 50,470 shares of ContraVir Pharmaceuticals, Inc. (CTRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert T. Foster has been a net buyer of CTRV stock. They have purchased $97.1K and sold $0 worth of shares.
Robert T. Foster's most recent insider trade was on Sep 18, 2023, when they purchased 1,600 shares at $5.60 per share.
Get notified when new Form 4 filings are submitted
| $5.40 |
| Discretionary |
| Feb 18, 2021 | HEPA | $40.0K | Purchase | 20,000 | $2.00 | Discretionary |
| Dec 8, 2020 | HEPA | $39.5K | Purchase | 25,000 | $1.58 | Discretionary |
| Jan 3, 2018 | CTRV | $0 | Award | 100,654 | $N/A | Discretionary |
| Jul 6, 2017 | CTRV | $0 | Award | 44,082 | $N/A | Discretionary |